Selected article for: "cell culture and diagnostic testing"

Author: Gupta, Neha; Richter, Robert; Robert, Stephen; Kong, Michele
Title: Viral Sepsis in Children
  • Document date: 2018_9_18
  • ID: 050vjj6k_25
    Snippet: There are currently no standard approaches to viral diagnostic testing. Point-of-care (POC) antigen-based testing is relatively inexpensive and provides rapid detection of common respiratory viruses from a nasopharyngeal swab, such as RSV or common strains of human influenza. However, POC testing may lack the sensitivity needed to determine the etiology of life-threatening sepsis (106) . Direct fluorescent antibody (DFA) testing may provide bette.....
    Document: There are currently no standard approaches to viral diagnostic testing. Point-of-care (POC) antigen-based testing is relatively inexpensive and provides rapid detection of common respiratory viruses from a nasopharyngeal swab, such as RSV or common strains of human influenza. However, POC testing may lack the sensitivity needed to determine the etiology of life-threatening sepsis (106) . Direct fluorescent antibody (DFA) testing may provide better specificity and a broader range of viral strain detection than POC testing, but the test depends on the collection of sufficient numbers of epithelial cells for adequate viral detection (107) . Cell culture is the traditional gold-standard for viral diagnoses, including for HSV, however the long turn-around time for results significantly limits its utility for expedient diagnosis (108) . Commercial or laboratory-developed nucleic acid amplification tests (NAATs) (e.g., polymerase chain reaction, PCR, or reverse transcription-loop-mediated isothermal amplification) may provide greater sensitivity and specificity than POC or DFA testing but requires sophisticated equipment and specially trained laboratory staff to complete (109, 110) . NAATs have the added benefit of being highly multiplexed with new commercially available technology like Biofire R FilmArray R multiplex PCR (111) . Unfortunately, the use of NAATs is limited by the high cost, delay in results and the inability to distinguish between viral nucleic acids from live viruses (112) . Ultimately, the methods available for timely viral detection are limited by technique of sample collection and institutional resource availability.

    Search related documents:
    Co phrase search for related documents
    • broad range and care point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • broad range and cell culture: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • broad range and chain reaction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • broad range and commercially available technology: 1
    • broad range and common respiratory virus: 1, 2
    • broad range and DFA direct fluorescent antibody: 1, 2
    • broad range and DFA direct fluorescent antibody testing: 1
    • broad range and DFA testing: 1
    • broad range and diagnostic testing: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • broad range and direct fluorescent: 1, 2
    • broad range and direct fluorescent antibody: 1, 2
    • broad range and epithelial cell: 1, 2, 3, 4, 5, 6
    • care point and cell culture: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • care point and DFA direct fluorescent antibody: 1
    • care point and DFA testing: 1
    • care point and diagnostic testing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • care point and direct fluorescent: 1
    • care point and direct fluorescent antibody: 1
    • care point and epithelial cell: 1